Therapies and Procedures
AtriCure offers a robust portfolio of products used in some of the most complex therapies and procedures.
- Healthcare Professionals
- Patients & Caregivers
- About AtriCure
First Patient Treated in LeAAPS Clinical Trial
Safety & effectiveness study to evaluate if prophylactic left atrial appendage exclusion reduces occurrence of ischemic stroke or systemic embolism in cardiac surgery patients with elevated risk of stroke and no history of atrial fibrillation
Hybrid AF Therapy with EPi-Sense System
Minimally Invasive Ablation Therapy for the Treatment of Advanced Atrial Fibrillation
Providing Several Months of Post-Operative Pain Relief
Cryo Nerve Block Therapy uses a unique freezing method to temporarily block pain signals from the nerves.
Top Workplaces 2023
Ready to work at a Top Workplace?
First Patient Treated in HEAL-IST™ Trial
Trial will evaluate the safety and effectiveness of AtriCure’s Isolator Synergy Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia
We are Humbled by Our Talented Board and Employees!
Our responsibility to advance Diversity, Equity, and Inclusion is driven by a passionate belief that diverse thinking, skills, and experience bring the best outcome to our work as we innovate products and therapies that improve patients’ lives.
0
Patients Served with Ablation Worldwide
0
AtriClip Devices Sold Worldwide
NEWS
AtriCure Reports Second Quarter 2023 Financial Results
REDUCING GLOBAL AFIB
What is Afib, and how does it affect heart performance?
CAREERS
Interested in joining our mission to reduce the global Afib epidemic?
THERAPY INNOVATION
Post-Operative Pain Management: Opening the Door to Some Cool Options
PM-APAC-2655A-0525-G
© 2023 Atricure, Inc. All Rights Reserved.
The EnCompass® Clamp is the newest innovation in bipolar RF ablation. EnCompass provides a magnetic guide, parallel closure, and uniform tissue pressure – while harnessing the technology we know works well.
The EnCompass® Clamp is the newest innovation in bipolar RF ablation. EnCompass provides a magnetic guide, parallel closure, and uniform tissue pressure – while harnessing the technology we know works well.
We're grateful for the skilled #SurgicalTechs who ensure safe and smooth operating rooms each day. Thank you for all you do! #SurgicalTechWeek
We're grateful for the skilled #SurgicalTechs who ensure safe and smooth operating rooms each day. Thank you for all you do! #SurgicalTechWeek
Do you have patients with inappropriate sinus tachycardia (IST)? If they’ve become refractory or intolerant to medications, they may be a candidate for the HEAL-IST Trial. For participation criteria and study details, visit https://bit.ly/clinical-heal-ist
Do you have patients with inappropriate sinus tachycardia (IST)? If they’ve become refractory or intolerant to medications, they may be a candidate for the HEAL-IST Trial. For participation criteria and study details, visit https://bit.ly/clinical-heal-ist
A metanalysis of CONVERGE and Real-World Data showed a 30-day major adverse event rate of 4% with a 95% confidence interval of 3-6% among more than 1,100 Hybrid Convergent Patients studied. See more #HybridAFTherapy data at https://bit.ly/47WQBk8
A metanalysis of CONVERGE and Real-World Data showed a 30-day major adverse event rate of 4% with a 95% confidence interval of 3-6% among more than 1,100 Hybrid Convergent Patients studied. See more #HybridAFTherapy data at https://bit.ly/47WQBk8
social media channels to keep updated on the latest at AtriCure.